nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP2A6—Amobarbital—epilepsy syndrome	0.107	0.161	CbGbCtD
Letrozole—CYP2A6—Propofol—epilepsy syndrome	0.0797	0.12	CbGbCtD
Letrozole—CYP2A6—Phenobarbital—epilepsy syndrome	0.0762	0.115	CbGbCtD
Letrozole—CYP2A6—Valproic Acid—epilepsy syndrome	0.057	0.0856	CbGbCtD
Letrozole—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0304	0.0456	CbGbCtD
Letrozole—CYP3A4—Felbamate—epilepsy syndrome	0.0282	0.0424	CbGbCtD
Letrozole—CYP3A4—Trimethadione—epilepsy syndrome	0.0282	0.0424	CbGbCtD
Letrozole—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0265	0.0399	CbGbCtD
Letrozole—CYP3A4—Clonazepam—epilepsy syndrome	0.024	0.0361	CbGbCtD
Letrozole—CYP3A4—Clobazam—epilepsy syndrome	0.023	0.0346	CbGbCtD
Letrozole—CYP3A4—Rufinamide—epilepsy syndrome	0.0196	0.0294	CbGbCtD
Letrozole—CYP3A4—Carbamazepine—epilepsy syndrome	0.0191	0.0286	CbGbCtD
Letrozole—CYP3A4—Primidone—epilepsy syndrome	0.0178	0.0267	CbGbCtD
Letrozole—CYP3A4—Phenytoin—epilepsy syndrome	0.0171	0.0257	CbGbCtD
Letrozole—CYP3A4—Propofol—epilepsy syndrome	0.0159	0.024	CbGbCtD
Letrozole—CYP3A4—Acetazolamide—epilepsy syndrome	0.0152	0.0229	CbGbCtD
Letrozole—CYP3A4—Phenobarbital—epilepsy syndrome	0.0152	0.0229	CbGbCtD
Letrozole—CYP3A4—Midazolam—epilepsy syndrome	0.015	0.0226	CbGbCtD
Letrozole—CYP3A4—Diazepam—epilepsy syndrome	0.0144	0.0217	CbGbCtD
Letrozole—CYP3A4—Zonisamide—epilepsy syndrome	0.0141	0.0212	CbGbCtD
Letrozole—CYP3A4—Valproic Acid—epilepsy syndrome	0.0114	0.0171	CbGbCtD
Letrozole—CYP3A4—Topiramate—epilepsy syndrome	0.0103	0.0154	CbGbCtD
Letrozole—Bifonazole—CYP2C19—epilepsy syndrome	0.000322	1	CrCbGaD
Letrozole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	0.000142	0.00454	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.000142	0.00452	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.00014	0.00445	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.00014	0.00445	CbGpPWpGaD
Letrozole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	0.000134	0.00428	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—ABCC2—epilepsy syndrome	0.000131	0.00419	CbGpPWpGaD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	0.000122	0.0039	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—SLC6A1—epilepsy syndrome	0.000122	0.00389	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP2C19—epilepsy syndrome	0.00012	0.00382	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TSC1—epilepsy syndrome	0.000119	0.0038	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP11A1—epilepsy syndrome	0.000119	0.0038	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.000118	0.00377	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.000118	0.00375	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP2D6—epilepsy syndrome	0.000108	0.00343	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	0.000106	0.00338	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.000106	0.00337	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000105	0.00333	CbGpPWpGaD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	9.92e-05	0.00316	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—SLC6A4—epilepsy syndrome	9.76e-05	0.00311	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	9.74e-05	0.0031	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	9.68e-05	0.00308	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP2C19—epilepsy syndrome	9.55e-05	0.00304	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP11A1—epilepsy syndrome	9.49e-05	0.00302	CbGpPWpGaD
Letrozole—Diarrhoea—Zonisamide—epilepsy syndrome	9.45e-05	0.000312	CcSEcCtD
Letrozole—Asthenia—Oxcarbazepine—epilepsy syndrome	9.44e-05	0.000312	CcSEcCtD
Letrozole—Pruritus—Clonazepam—epilepsy syndrome	9.42e-05	0.000311	CcSEcCtD
Letrozole—Vomiting—Vigabatrin—epilepsy syndrome	9.42e-05	0.000311	CcSEcCtD
Letrozole—Skin disorder—Valproic Acid—epilepsy syndrome	9.42e-05	0.000311	CcSEcCtD
Letrozole—Urinary tract disorder—Topiramate—epilepsy syndrome	9.4e-05	0.00031	CcSEcCtD
Letrozole—Oedema peripheral—Topiramate—epilepsy syndrome	9.37e-05	0.00031	CcSEcCtD
Letrozole—Hyperhidrosis—Valproic Acid—epilepsy syndrome	9.37e-05	0.000309	CcSEcCtD
Letrozole—Cough—Pregabalin—epilepsy syndrome	9.37e-05	0.000309	CcSEcCtD
Letrozole—Pruritus—Phenytoin—epilepsy syndrome	9.35e-05	0.000309	CcSEcCtD
Letrozole—Connective tissue disorder—Topiramate—epilepsy syndrome	9.35e-05	0.000309	CcSEcCtD
Letrozole—Nausea—Levetiracetam—epilepsy syndrome	9.35e-05	0.000309	CcSEcCtD
Letrozole—Rash—Vigabatrin—epilepsy syndrome	9.34e-05	0.000308	CcSEcCtD
Letrozole—Dizziness—Felbamate—epilepsy syndrome	9.33e-05	0.000308	CcSEcCtD
Letrozole—Dermatitis—Vigabatrin—epilepsy syndrome	9.33e-05	0.000308	CcSEcCtD
Letrozole—Urethral disorder—Topiramate—epilepsy syndrome	9.33e-05	0.000308	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	9.32e-05	0.00297	CbGpPWpGaD
Letrozole—Pruritus—Oxcarbazepine—epilepsy syndrome	9.31e-05	0.000307	CcSEcCtD
Letrozole—CYP19A1—FSH signaling pathway—AKT1—epilepsy syndrome	9.29e-05	0.00296	CbGpPWpGaD
Letrozole—Vision blurred—Gabapentin—epilepsy syndrome	9.28e-05	0.000306	CcSEcCtD
Letrozole—Headache—Vigabatrin—epilepsy syndrome	9.28e-05	0.000306	CcSEcCtD
Letrozole—Hypertension—Pregabalin—epilepsy syndrome	9.27e-05	0.000306	CcSEcCtD
Letrozole—Vomiting—Diazepam—epilepsy syndrome	9.27e-05	0.000306	CcSEcCtD
Letrozole—Anorexia—Valproic Acid—epilepsy syndrome	9.24e-05	0.000305	CcSEcCtD
Letrozole—Rash—Diazepam—epilepsy syndrome	9.19e-05	0.000304	CcSEcCtD
Letrozole—Dermatitis—Diazepam—epilepsy syndrome	9.18e-05	0.000303	CcSEcCtD
Letrozole—Myalgia—Pregabalin—epilepsy syndrome	9.14e-05	0.000302	CcSEcCtD
Letrozole—Arthralgia—Pregabalin—epilepsy syndrome	9.14e-05	0.000302	CcSEcCtD
Letrozole—Chest pain—Pregabalin—epilepsy syndrome	9.14e-05	0.000302	CcSEcCtD
Letrozole—Ill-defined disorder—Gabapentin—epilepsy syndrome	9.14e-05	0.000302	CcSEcCtD
Letrozole—Dizziness—Zonisamide—epilepsy syndrome	9.13e-05	0.000302	CcSEcCtD
Letrozole—Headache—Diazepam—epilepsy syndrome	9.13e-05	0.000302	CcSEcCtD
Letrozole—Anxiety—Pregabalin—epilepsy syndrome	9.11e-05	0.000301	CcSEcCtD
Letrozole—Diarrhoea—Clonazepam—epilepsy syndrome	9.11e-05	0.000301	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CDC42—epilepsy syndrome	9.09e-05	0.0029	CbGpPWpGaD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	9.08e-05	0.0003	CcSEcCtD
Letrozole—Asthenia—Carbamazepine—epilepsy syndrome	9.06e-05	0.000299	CcSEcCtD
Letrozole—Diarrhoea—Phenytoin—epilepsy syndrome	9.05e-05	0.000299	CcSEcCtD
Letrozole—Discomfort—Pregabalin—epilepsy syndrome	9.03e-05	0.000298	CcSEcCtD
Letrozole—Nausea—Fosphenytoin—epilepsy syndrome	9.02e-05	0.000298	CcSEcCtD
Letrozole—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9e-05	0.000297	CcSEcCtD
Letrozole—Erythema multiforme—Topiramate—epilepsy syndrome	9e-05	0.000297	CcSEcCtD
Letrozole—Angioedema—Gabapentin—epilepsy syndrome	9e-05	0.000297	CcSEcCtD
Letrozole—Vomiting—Felbamate—epilepsy syndrome	8.97e-05	0.000296	CcSEcCtD
Letrozole—Dry mouth—Pregabalin—epilepsy syndrome	8.94e-05	0.000295	CcSEcCtD
Letrozole—Pruritus—Carbamazepine—epilepsy syndrome	8.93e-05	0.000295	CcSEcCtD
Letrozole—Rash—Felbamate—epilepsy syndrome	8.9e-05	0.000294	CcSEcCtD
Letrozole—Eye disorder—Topiramate—epilepsy syndrome	8.89e-05	0.000294	CcSEcCtD
Letrozole—Dermatitis—Felbamate—epilepsy syndrome	8.89e-05	0.000294	CcSEcCtD
Letrozole—Malaise—Gabapentin—epilepsy syndrome	8.88e-05	0.000293	CcSEcCtD
Letrozole—Vertigo—Gabapentin—epilepsy syndrome	8.85e-05	0.000292	CcSEcCtD
Letrozole—Headache—Felbamate—epilepsy syndrome	8.84e-05	0.000292	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	8.83e-05	0.000292	CcSEcCtD
Letrozole—Flushing—Topiramate—epilepsy syndrome	8.83e-05	0.000292	CcSEcCtD
Letrozole—Cardiac disorder—Topiramate—epilepsy syndrome	8.83e-05	0.000292	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—SLC2A1—epilepsy syndrome	8.83e-05	0.00281	CbGpPWpGaD
Letrozole—Leukopenia—Gabapentin—epilepsy syndrome	8.81e-05	0.000291	CcSEcCtD
Letrozole—Dizziness—Clonazepam—epilepsy syndrome	8.8e-05	0.000291	CcSEcCtD
Letrozole—Nausea—Vigabatrin—epilepsy syndrome	8.8e-05	0.00029	CcSEcCtD
Letrozole—Vomiting—Zonisamide—epilepsy syndrome	8.78e-05	0.00029	CcSEcCtD
Letrozole—Insomnia—Valproic Acid—epilepsy syndrome	8.77e-05	0.00029	CcSEcCtD
Letrozole—Oedema—Pregabalin—epilepsy syndrome	8.76e-05	0.000289	CcSEcCtD
Letrozole—Anaphylactic shock—Pregabalin—epilepsy syndrome	8.76e-05	0.000289	CcSEcCtD
Letrozole—Asthenia—Lamotrigine—epilepsy syndrome	8.75e-05	0.000289	CcSEcCtD
Letrozole—Dizziness—Phenytoin—epilepsy syndrome	8.74e-05	0.000289	CcSEcCtD
Letrozole—Rash—Zonisamide—epilepsy syndrome	8.71e-05	0.000288	CcSEcCtD
Letrozole—Infection—Pregabalin—epilepsy syndrome	8.71e-05	0.000287	CcSEcCtD
Letrozole—Paraesthesia—Valproic Acid—epilepsy syndrome	8.7e-05	0.000287	CcSEcCtD
Letrozole—Palpitations—Gabapentin—epilepsy syndrome	8.7e-05	0.000287	CcSEcCtD
Letrozole—Dermatitis—Zonisamide—epilepsy syndrome	8.7e-05	0.000287	CcSEcCtD
Letrozole—Dizziness—Oxcarbazepine—epilepsy syndrome	8.7e-05	0.000287	CcSEcCtD
Letrozole—Nausea—Diazepam—epilepsy syndrome	8.66e-05	0.000286	CcSEcCtD
Letrozole—Headache—Zonisamide—epilepsy syndrome	8.65e-05	0.000286	CcSEcCtD
Letrozole—Dyspnoea—Valproic Acid—epilepsy syndrome	8.64e-05	0.000285	CcSEcCtD
Letrozole—Diarrhoea—Carbamazepine—epilepsy syndrome	8.64e-05	0.000285	CcSEcCtD
Letrozole—Angiopathy—Topiramate—epilepsy syndrome	8.63e-05	0.000285	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—epilepsy syndrome	8.63e-05	0.00275	CbGpPWpGaD
Letrozole—Pruritus—Lamotrigine—epilepsy syndrome	8.63e-05	0.000285	CcSEcCtD
Letrozole—Somnolence—Valproic Acid—epilepsy syndrome	8.62e-05	0.000285	CcSEcCtD
Letrozole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	8.61e-05	0.00274	CbGpPWpGaD
Letrozole—Nervous system disorder—Pregabalin—epilepsy syndrome	8.59e-05	0.000284	CcSEcCtD
Letrozole—Cough—Gabapentin—epilepsy syndrome	8.59e-05	0.000284	CcSEcCtD
Letrozole—Mediastinal disorder—Topiramate—epilepsy syndrome	8.58e-05	0.000283	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—CYP2D6—epilepsy syndrome	8.56e-05	0.00273	CbGpPWpGaD
Letrozole—Tachycardia—Pregabalin—epilepsy syndrome	8.55e-05	0.000282	CcSEcCtD
Letrozole—Dyspepsia—Valproic Acid—epilepsy syndrome	8.53e-05	0.000282	CcSEcCtD
Letrozole—Skin disorder—Pregabalin—epilepsy syndrome	8.51e-05	0.000281	CcSEcCtD
Letrozole—Hypertension—Gabapentin—epilepsy syndrome	8.5e-05	0.000281	CcSEcCtD
Letrozole—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.47e-05	0.00028	CcSEcCtD
Letrozole—Vomiting—Clonazepam—epilepsy syndrome	8.46e-05	0.000279	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	8.46e-05	0.0027	CbGpPWpGaD
Letrozole—Decreased appetite—Valproic Acid—epilepsy syndrome	8.43e-05	0.000278	CcSEcCtD
Letrozole—Alopecia—Topiramate—epilepsy syndrome	8.41e-05	0.000278	CcSEcCtD
Letrozole—Vomiting—Phenytoin—epilepsy syndrome	8.41e-05	0.000278	CcSEcCtD
Letrozole—Rash—Clonazepam—epilepsy syndrome	8.39e-05	0.000277	CcSEcCtD
Letrozole—Dermatitis—Clonazepam—epilepsy syndrome	8.39e-05	0.000277	CcSEcCtD
Letrozole—Arthralgia—Gabapentin—epilepsy syndrome	8.38e-05	0.000277	CcSEcCtD
Letrozole—Chest pain—Gabapentin—epilepsy syndrome	8.38e-05	0.000277	CcSEcCtD
Letrozole—Myalgia—Gabapentin—epilepsy syndrome	8.38e-05	0.000277	CcSEcCtD
Letrozole—Nausea—Felbamate—epilepsy syndrome	8.38e-05	0.000277	CcSEcCtD
Letrozole—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.37e-05	0.000276	CcSEcCtD
Letrozole—Vomiting—Oxcarbazepine—epilepsy syndrome	8.36e-05	0.000276	CcSEcCtD
Letrozole—Fatigue—Valproic Acid—epilepsy syndrome	8.36e-05	0.000276	CcSEcCtD
Letrozole—Anxiety—Gabapentin—epilepsy syndrome	8.35e-05	0.000276	CcSEcCtD
Letrozole—Anorexia—Pregabalin—epilepsy syndrome	8.35e-05	0.000276	CcSEcCtD
Letrozole—Dizziness—Carbamazepine—epilepsy syndrome	8.35e-05	0.000276	CcSEcCtD
Letrozole—Diarrhoea—Lamotrigine—epilepsy syndrome	8.35e-05	0.000276	CcSEcCtD
Letrozole—Headache—Clonazepam—epilepsy syndrome	8.34e-05	0.000275	CcSEcCtD
Letrozole—Rash—Phenytoin—epilepsy syndrome	8.34e-05	0.000275	CcSEcCtD
Letrozole—Mental disorder—Topiramate—epilepsy syndrome	8.34e-05	0.000275	CcSEcCtD
Letrozole—Dermatitis—Phenytoin—epilepsy syndrome	8.33e-05	0.000275	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.32e-05	0.000275	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—HBEGF—epilepsy syndrome	8.3e-05	0.00265	CbGpPWpGaD
Letrozole—Rash—Oxcarbazepine—epilepsy syndrome	8.29e-05	0.000274	CcSEcCtD
Letrozole—Constipation—Valproic Acid—epilepsy syndrome	8.29e-05	0.000274	CcSEcCtD
Letrozole—Pain—Valproic Acid—epilepsy syndrome	8.29e-05	0.000274	CcSEcCtD
Letrozole—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.29e-05	0.000274	CcSEcCtD
Letrozole—Headache—Phenytoin—epilepsy syndrome	8.28e-05	0.000274	CcSEcCtD
Letrozole—Malnutrition—Topiramate—epilepsy syndrome	8.28e-05	0.000274	CcSEcCtD
Letrozole—Discomfort—Gabapentin—epilepsy syndrome	8.28e-05	0.000273	CcSEcCtD
Letrozole—Headache—Oxcarbazepine—epilepsy syndrome	8.24e-05	0.000272	CcSEcCtD
Letrozole—CYP19A1—Metabolism—CA13—epilepsy syndrome	8.21e-05	0.00261	CbGpPWpGaD
Letrozole—Nausea—Zonisamide—epilepsy syndrome	8.2e-05	0.000271	CcSEcCtD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	8.2e-05	0.00261	CbGpPWpGaD
Letrozole—Dry mouth—Gabapentin—epilepsy syndrome	8.2e-05	0.000271	CcSEcCtD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	8.18e-05	0.00261	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	8.13e-05	0.00259	CbGpPWpGaD
Letrozole—Tension—Topiramate—epilepsy syndrome	8.13e-05	0.000268	CcSEcCtD
Letrozole—Dysgeusia—Topiramate—epilepsy syndrome	8.11e-05	0.000268	CcSEcCtD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	8.08e-05	0.00257	CbGpPWpGaD
Letrozole—Dizziness—Lamotrigine—epilepsy syndrome	8.07e-05	0.000266	CcSEcCtD
Letrozole—Nervousness—Topiramate—epilepsy syndrome	8.05e-05	0.000266	CcSEcCtD
Letrozole—Oedema—Gabapentin—epilepsy syndrome	8.04e-05	0.000265	CcSEcCtD
Letrozole—Anaphylactic shock—Gabapentin—epilepsy syndrome	8.04e-05	0.000265	CcSEcCtD
Letrozole—Vomiting—Carbamazepine—epilepsy syndrome	8.02e-05	0.000265	CcSEcCtD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	8.02e-05	0.00256	CbGpPWpGaD
Letrozole—Back pain—Topiramate—epilepsy syndrome	8.01e-05	0.000265	CcSEcCtD
Letrozole—Feeling abnormal—Valproic Acid—epilepsy syndrome	7.99e-05	0.000264	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.98e-05	0.000264	CcSEcCtD
Letrozole—Infection—Gabapentin—epilepsy syndrome	7.98e-05	0.000264	CcSEcCtD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	7.97e-05	0.00254	CbGpPWpGaD
Letrozole—Rash—Carbamazepine—epilepsy syndrome	7.96e-05	0.000263	CcSEcCtD
Letrozole—Dermatitis—Carbamazepine—epilepsy syndrome	7.95e-05	0.000263	CcSEcCtD
Letrozole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.93e-05	0.000262	CcSEcCtD
Letrozole—Insomnia—Pregabalin—epilepsy syndrome	7.93e-05	0.000262	CcSEcCtD
Letrozole—Nausea—Clonazepam—epilepsy syndrome	7.91e-05	0.000261	CcSEcCtD
Letrozole—Headache—Carbamazepine—epilepsy syndrome	7.91e-05	0.000261	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	7.9e-05	0.00252	CbGpPWpGaD
Letrozole—Nervous system disorder—Gabapentin—epilepsy syndrome	7.88e-05	0.00026	CcSEcCtD
Letrozole—Paraesthesia—Pregabalin—epilepsy syndrome	7.87e-05	0.00026	CcSEcCtD
Letrozole—Nausea—Phenytoin—epilepsy syndrome	7.85e-05	0.000259	CcSEcCtD
Letrozole—Tachycardia—Gabapentin—epilepsy syndrome	7.84e-05	0.000259	CcSEcCtD
Letrozole—Dyspnoea—Pregabalin—epilepsy syndrome	7.81e-05	0.000258	CcSEcCtD
Letrozole—Nausea—Oxcarbazepine—epilepsy syndrome	7.81e-05	0.000258	CcSEcCtD
Letrozole—Vision blurred—Topiramate—epilepsy syndrome	7.81e-05	0.000258	CcSEcCtD
Letrozole—Skin disorder—Gabapentin—epilepsy syndrome	7.81e-05	0.000258	CcSEcCtD
Letrozole—Somnolence—Pregabalin—epilepsy syndrome	7.79e-05	0.000257	CcSEcCtD
Letrozole—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.77e-05	0.000257	CcSEcCtD
Letrozole—Vomiting—Lamotrigine—epilepsy syndrome	7.76e-05	0.000256	CcSEcCtD
Letrozole—Urticaria—Valproic Acid—epilepsy syndrome	7.7e-05	0.000254	CcSEcCtD
Letrozole—Rash—Lamotrigine—epilepsy syndrome	7.69e-05	0.000254	CcSEcCtD
Letrozole—Ill-defined disorder—Topiramate—epilepsy syndrome	7.69e-05	0.000254	CcSEcCtD
Letrozole—Dermatitis—Lamotrigine—epilepsy syndrome	7.68e-05	0.000254	CcSEcCtD
Letrozole—Abdominal pain—Valproic Acid—epilepsy syndrome	7.66e-05	0.000253	CcSEcCtD
Letrozole—Body temperature increased—Valproic Acid—epilepsy syndrome	7.66e-05	0.000253	CcSEcCtD
Letrozole—Anorexia—Gabapentin—epilepsy syndrome	7.66e-05	0.000253	CcSEcCtD
Letrozole—Headache—Lamotrigine—epilepsy syndrome	7.64e-05	0.000252	CcSEcCtD
Letrozole—Decreased appetite—Pregabalin—epilepsy syndrome	7.62e-05	0.000252	CcSEcCtD
Letrozole—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.57e-05	0.00025	CcSEcCtD
Letrozole—Fatigue—Pregabalin—epilepsy syndrome	7.56e-05	0.000249	CcSEcCtD
Letrozole—Nausea—Carbamazepine—epilepsy syndrome	7.5e-05	0.000248	CcSEcCtD
Letrozole—Constipation—Pregabalin—epilepsy syndrome	7.49e-05	0.000247	CcSEcCtD
Letrozole—Pain—Pregabalin—epilepsy syndrome	7.49e-05	0.000247	CcSEcCtD
Letrozole—Malaise—Topiramate—epilepsy syndrome	7.47e-05	0.000247	CcSEcCtD
Letrozole—Vertigo—Topiramate—epilepsy syndrome	7.44e-05	0.000246	CcSEcCtD
Letrozole—Leukopenia—Topiramate—epilepsy syndrome	7.41e-05	0.000245	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.32e-05	0.000242	CcSEcCtD
Letrozole—Palpitations—Topiramate—epilepsy syndrome	7.32e-05	0.000242	CcSEcCtD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	7.29e-05	0.00232	CbGpPWpGaD
Letrozole—Insomnia—Gabapentin—epilepsy syndrome	7.27e-05	0.00024	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—HMOX1—epilepsy syndrome	7.26e-05	0.00231	CbGpPWpGaD
Letrozole—Nausea—Lamotrigine—epilepsy syndrome	7.25e-05	0.000239	CcSEcCtD
Letrozole—Cough—Topiramate—epilepsy syndrome	7.23e-05	0.000239	CcSEcCtD
Letrozole—Feeling abnormal—Pregabalin—epilepsy syndrome	7.22e-05	0.000238	CcSEcCtD
Letrozole—Paraesthesia—Gabapentin—epilepsy syndrome	7.22e-05	0.000238	CcSEcCtD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	7.2e-05	0.00229	CbGpPWpGaD
Letrozole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.17e-05	0.000237	CcSEcCtD
Letrozole—Dyspnoea—Gabapentin—epilepsy syndrome	7.16e-05	0.000237	CcSEcCtD
Letrozole—Hypertension—Topiramate—epilepsy syndrome	7.15e-05	0.000236	CcSEcCtD
Letrozole—Somnolence—Gabapentin—epilepsy syndrome	7.14e-05	0.000236	CcSEcCtD
Letrozole—Dyspepsia—Gabapentin—epilepsy syndrome	7.07e-05	0.000234	CcSEcCtD
Letrozole—Arthralgia—Topiramate—epilepsy syndrome	7.05e-05	0.000233	CcSEcCtD
Letrozole—Myalgia—Topiramate—epilepsy syndrome	7.05e-05	0.000233	CcSEcCtD
Letrozole—Chest pain—Topiramate—epilepsy syndrome	7.05e-05	0.000233	CcSEcCtD
Letrozole—Anxiety—Topiramate—epilepsy syndrome	7.03e-05	0.000232	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7e-05	0.000231	CcSEcCtD
Letrozole—Decreased appetite—Gabapentin—epilepsy syndrome	6.99e-05	0.000231	CcSEcCtD
Letrozole—Discomfort—Topiramate—epilepsy syndrome	6.97e-05	0.00023	CcSEcCtD
Letrozole—Urticaria—Pregabalin—epilepsy syndrome	6.96e-05	0.00023	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TSC2—epilepsy syndrome	6.96e-05	0.00222	CbGpPWpGaD
Letrozole—Asthenia—Valproic Acid—epilepsy syndrome	6.95e-05	0.00023	CcSEcCtD
Letrozole—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.94e-05	0.000229	CcSEcCtD
Letrozole—Fatigue—Gabapentin—epilepsy syndrome	6.93e-05	0.000229	CcSEcCtD
Letrozole—Abdominal pain—Pregabalin—epilepsy syndrome	6.93e-05	0.000229	CcSEcCtD
Letrozole—Body temperature increased—Pregabalin—epilepsy syndrome	6.93e-05	0.000229	CcSEcCtD
Letrozole—Dry mouth—Topiramate—epilepsy syndrome	6.9e-05	0.000228	CcSEcCtD
Letrozole—Pain—Gabapentin—epilepsy syndrome	6.87e-05	0.000227	CcSEcCtD
Letrozole—Constipation—Gabapentin—epilepsy syndrome	6.87e-05	0.000227	CcSEcCtD
Letrozole—Pruritus—Valproic Acid—epilepsy syndrome	6.86e-05	0.000226	CcSEcCtD
Letrozole—Oedema—Topiramate—epilepsy syndrome	6.76e-05	0.000223	CcSEcCtD
Letrozole—Infection—Topiramate—epilepsy syndrome	6.72e-05	0.000222	CcSEcCtD
Letrozole—Diarrhoea—Valproic Acid—epilepsy syndrome	6.63e-05	0.000219	CcSEcCtD
Letrozole—Nervous system disorder—Topiramate—epilepsy syndrome	6.63e-05	0.000219	CcSEcCtD
Letrozole—Feeling abnormal—Gabapentin—epilepsy syndrome	6.62e-05	0.000219	CcSEcCtD
Letrozole—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	6.62e-05	0.00211	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	6.6e-05	0.0021	CbGpPWpGaD
Letrozole—Tachycardia—Topiramate—epilepsy syndrome	6.6e-05	0.000218	CcSEcCtD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	6.59e-05	0.0021	CbGpPWpGaD
Letrozole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.57e-05	0.000217	CcSEcCtD
Letrozole—Skin disorder—Topiramate—epilepsy syndrome	6.57e-05	0.000217	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—ATM—epilepsy syndrome	6.56e-05	0.00209	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	6.55e-05	0.00209	CbGpPWpGaD
Letrozole—Hyperhidrosis—Topiramate—epilepsy syndrome	6.54e-05	0.000216	CcSEcCtD
Letrozole—CYP2A6—Metabolism—CA13—epilepsy syndrome	6.53e-05	0.00208	CbGpPWpGaD
Letrozole—Anorexia—Topiramate—epilepsy syndrome	6.44e-05	0.000213	CcSEcCtD
Letrozole—Dizziness—Valproic Acid—epilepsy syndrome	6.41e-05	0.000212	CcSEcCtD
Letrozole—Urticaria—Gabapentin—epilepsy syndrome	6.38e-05	0.000211	CcSEcCtD
Letrozole—Abdominal pain—Gabapentin—epilepsy syndrome	6.35e-05	0.00021	CcSEcCtD
Letrozole—Body temperature increased—Gabapentin—epilepsy syndrome	6.35e-05	0.00021	CcSEcCtD
Letrozole—Asthenia—Pregabalin—epilepsy syndrome	6.29e-05	0.000208	CcSEcCtD
Letrozole—CYP19A1—Metabolism—CERS1—epilepsy syndrome	6.22e-05	0.00198	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PDXK—epilepsy syndrome	6.22e-05	0.00198	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—FAR1—epilepsy syndrome	6.22e-05	0.00198	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GLUD1—epilepsy syndrome	6.22e-05	0.00198	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ADK—epilepsy syndrome	6.22e-05	0.00198	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—L2HGDH—epilepsy syndrome	6.22e-05	0.00198	CbGpPWpGaD
Letrozole—Pruritus—Pregabalin—epilepsy syndrome	6.2e-05	0.000205	CcSEcCtD
Letrozole—Vomiting—Valproic Acid—epilepsy syndrome	6.16e-05	0.000204	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.16e-05	0.000203	CcSEcCtD
Letrozole—Insomnia—Topiramate—epilepsy syndrome	6.11e-05	0.000202	CcSEcCtD
Letrozole—Rash—Valproic Acid—epilepsy syndrome	6.11e-05	0.000202	CcSEcCtD
Letrozole—Dermatitis—Valproic Acid—epilepsy syndrome	6.11e-05	0.000202	CcSEcCtD
Letrozole—Headache—Valproic Acid—epilepsy syndrome	6.07e-05	0.000201	CcSEcCtD
Letrozole—Paraesthesia—Topiramate—epilepsy syndrome	6.07e-05	0.0002	CcSEcCtD
Letrozole—Dyspnoea—Topiramate—epilepsy syndrome	6.03e-05	0.000199	CcSEcCtD
Letrozole—Somnolence—Topiramate—epilepsy syndrome	6.01e-05	0.000198	CcSEcCtD
Letrozole—Diarrhoea—Pregabalin—epilepsy syndrome	6e-05	0.000198	CcSEcCtD
Letrozole—Dyspepsia—Topiramate—epilepsy syndrome	5.95e-05	0.000197	CcSEcCtD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	5.91e-05	0.00188	CbGpPWpGaD
Letrozole—Decreased appetite—Topiramate—epilepsy syndrome	5.88e-05	0.000194	CcSEcCtD
Letrozole—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.84e-05	0.000193	CcSEcCtD
Letrozole—Fatigue—Topiramate—epilepsy syndrome	5.83e-05	0.000192	CcSEcCtD
Letrozole—Dizziness—Pregabalin—epilepsy syndrome	5.79e-05	0.000191	CcSEcCtD
Letrozole—Pain—Topiramate—epilepsy syndrome	5.78e-05	0.000191	CcSEcCtD
Letrozole—Constipation—Topiramate—epilepsy syndrome	5.78e-05	0.000191	CcSEcCtD
Letrozole—Asthenia—Gabapentin—epilepsy syndrome	5.77e-05	0.00019	CcSEcCtD
Letrozole—Nausea—Valproic Acid—epilepsy syndrome	5.76e-05	0.00019	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	5.72e-05	0.00182	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—EPM2A—epilepsy syndrome	5.69e-05	0.00181	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NHLRC1—epilepsy syndrome	5.69e-05	0.00181	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GAMT—epilepsy syndrome	5.69e-05	0.00181	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PNPO—epilepsy syndrome	5.69e-05	0.00181	CbGpPWpGaD
Letrozole—Pruritus—Gabapentin—epilepsy syndrome	5.69e-05	0.000188	CcSEcCtD
Letrozole—Vomiting—Pregabalin—epilepsy syndrome	5.57e-05	0.000184	CcSEcCtD
Letrozole—Feeling abnormal—Topiramate—epilepsy syndrome	5.57e-05	0.000184	CcSEcCtD
Letrozole—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.53e-05	0.000183	CcSEcCtD
Letrozole—Rash—Pregabalin—epilepsy syndrome	5.53e-05	0.000182	CcSEcCtD
Letrozole—Dermatitis—Pregabalin—epilepsy syndrome	5.52e-05	0.000182	CcSEcCtD
Letrozole—Diarrhoea—Gabapentin—epilepsy syndrome	5.5e-05	0.000182	CcSEcCtD
Letrozole—Headache—Pregabalin—epilepsy syndrome	5.49e-05	0.000181	CcSEcCtD
Letrozole—Urticaria—Topiramate—epilepsy syndrome	5.37e-05	0.000177	CcSEcCtD
Letrozole—Body temperature increased—Topiramate—epilepsy syndrome	5.34e-05	0.000176	CcSEcCtD
Letrozole—Abdominal pain—Topiramate—epilepsy syndrome	5.34e-05	0.000176	CcSEcCtD
Letrozole—Dizziness—Gabapentin—epilepsy syndrome	5.31e-05	0.000175	CcSEcCtD
Letrozole—CYP19A1—Metabolism—QDPR—epilepsy syndrome	5.29e-05	0.00168	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CA4—epilepsy syndrome	5.29e-05	0.00168	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—POMC—epilepsy syndrome	5.27e-05	0.00168	CbGpPWpGaD
Letrozole—Nausea—Pregabalin—epilepsy syndrome	5.21e-05	0.000172	CcSEcCtD
Letrozole—Vomiting—Gabapentin—epilepsy syndrome	5.11e-05	0.000169	CcSEcCtD
Letrozole—Rash—Gabapentin—epilepsy syndrome	5.07e-05	0.000167	CcSEcCtD
Letrozole—Dermatitis—Gabapentin—epilepsy syndrome	5.06e-05	0.000167	CcSEcCtD
Letrozole—Headache—Gabapentin—epilepsy syndrome	5.03e-05	0.000166	CcSEcCtD
Letrozole—CYP19A1—Metabolism—COX3—epilepsy syndrome	4.97e-05	0.00158	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—L2HGDH—epilepsy syndrome	4.95e-05	0.00158	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PDXK—epilepsy syndrome	4.95e-05	0.00158	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CERS1—epilepsy syndrome	4.95e-05	0.00158	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GLUD1—epilepsy syndrome	4.95e-05	0.00158	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—FAR1—epilepsy syndrome	4.95e-05	0.00158	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ADK—epilepsy syndrome	4.95e-05	0.00158	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	4.91e-05	0.00156	CbGpPWpGaD
Letrozole—Asthenia—Topiramate—epilepsy syndrome	4.85e-05	0.00016	CcSEcCtD
Letrozole—Pruritus—Topiramate—epilepsy syndrome	4.78e-05	0.000158	CcSEcCtD
Letrozole—Nausea—Gabapentin—epilepsy syndrome	4.77e-05	0.000158	CcSEcCtD
Letrozole—CYP19A1—Metabolism—CACNA2D2—epilepsy syndrome	4.71e-05	0.0015	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—KCNB1—epilepsy syndrome	4.71e-05	0.0015	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PFKL—epilepsy syndrome	4.71e-05	0.0015	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLCO1A2—epilepsy syndrome	4.71e-05	0.0015	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC6A8—epilepsy syndrome	4.71e-05	0.0015	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	4.71e-05	0.0015	CbGpPWpGaD
Letrozole—Diarrhoea—Topiramate—epilepsy syndrome	4.63e-05	0.000153	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	4.61e-05	0.00147	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	4.58e-05	0.00146	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PNPO—epilepsy syndrome	4.53e-05	0.00144	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GAMT—epilepsy syndrome	4.53e-05	0.00144	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—EPM2A—epilepsy syndrome	4.53e-05	0.00144	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NHLRC1—epilepsy syndrome	4.53e-05	0.00144	CbGpPWpGaD
Letrozole—Dizziness—Topiramate—epilepsy syndrome	4.47e-05	0.000148	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	4.33e-05	0.00138	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NEU1—epilepsy syndrome	4.31e-05	0.00137	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—UPB1—epilepsy syndrome	4.31e-05	0.00137	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ATIC—epilepsy syndrome	4.31e-05	0.00137	CbGpPWpGaD
Letrozole—Vomiting—Topiramate—epilepsy syndrome	4.3e-05	0.000142	CcSEcCtD
Letrozole—Rash—Topiramate—epilepsy syndrome	4.26e-05	0.000141	CcSEcCtD
Letrozole—Dermatitis—Topiramate—epilepsy syndrome	4.26e-05	0.000141	CcSEcCtD
Letrozole—Headache—Topiramate—epilepsy syndrome	4.24e-05	0.00014	CcSEcCtD
Letrozole—CYP2A6—Metabolism—CA4—epilepsy syndrome	4.21e-05	0.00134	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—QDPR—epilepsy syndrome	4.21e-05	0.00134	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	4.21e-05	0.00134	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—POMC—epilepsy syndrome	4.2e-05	0.00134	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HSD17B4—epilepsy syndrome	4.15e-05	0.00132	CbGpPWpGaD
Letrozole—Nausea—Topiramate—epilepsy syndrome	4.02e-05	0.000133	CcSEcCtD
Letrozole—CYP19A1—Metabolism—PPP1R3C—epilepsy syndrome	4.01e-05	0.00128	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GBE1—epilepsy syndrome	4.01e-05	0.00128	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—COX3—epilepsy syndrome	3.96e-05	0.00126	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.92e-05	0.00125	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ASAH1—epilepsy syndrome	3.77e-05	0.0012	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PFKL—epilepsy syndrome	3.75e-05	0.0012	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLCO1A2—epilepsy syndrome	3.75e-05	0.0012	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—KCNB1—epilepsy syndrome	3.75e-05	0.0012	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CACNA2D2—epilepsy syndrome	3.75e-05	0.0012	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC6A8—epilepsy syndrome	3.75e-05	0.0012	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	3.68e-05	0.00117	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—STXBP1—epilepsy syndrome	3.67e-05	0.00117	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	3.57e-05	0.00114	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NT5E—epilepsy syndrome	3.57e-05	0.00114	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALAD—epilepsy syndrome	3.57e-05	0.00114	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	3.5e-05	0.00112	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	3.48e-05	0.00111	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	3.45e-05	0.0011	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3.43e-05	0.00109	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ATIC—epilepsy syndrome	3.43e-05	0.00109	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—UPB1—epilepsy syndrome	3.43e-05	0.00109	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NEU1—epilepsy syndrome	3.43e-05	0.00109	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALDH7A1—epilepsy syndrome	3.41e-05	0.00109	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CACNA1A—epilepsy syndrome	3.41e-05	0.00109	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ST3GAL3—epilepsy syndrome	3.33e-05	0.00106	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HSD17B4—epilepsy syndrome	3.3e-05	0.00105	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ADSL—epilepsy syndrome	3.27e-05	0.00104	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GLUL—epilepsy syndrome	3.2e-05	0.00102	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GBE1—epilepsy syndrome	3.19e-05	0.00102	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPP1R3C—epilepsy syndrome	3.19e-05	0.00102	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CACNA1D—epilepsy syndrome	3.14e-05	0.001	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	3.14e-05	0.001	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.1e-05	0.000987	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ASAH1—epilepsy syndrome	3e-05	0.000956	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—TXNRD1—epilepsy syndrome	2.94e-05	0.000937	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—STXBP1—epilepsy syndrome	2.92e-05	0.000929	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.9e-05	0.000923	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AQP1—epilepsy syndrome	2.86e-05	0.00091	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NT5E—epilepsy syndrome	2.84e-05	0.000906	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALAD—epilepsy syndrome	2.84e-05	0.000906	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.74e-05	0.000874	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALDH7A1—epilepsy syndrome	2.71e-05	0.000864	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CACNA1A—epilepsy syndrome	2.71e-05	0.000864	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ST3GAL3—epilepsy syndrome	2.65e-05	0.000846	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ADSL—epilepsy syndrome	2.6e-05	0.000828	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CHRM3—epilepsy syndrome	2.58e-05	0.000823	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—KCNJ11—epilepsy syndrome	2.58e-05	0.000823	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GLUL—epilepsy syndrome	2.55e-05	0.000812	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CACNA1D—epilepsy syndrome	2.5e-05	0.000797	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.4e-05	0.000766	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.39e-05	0.000763	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.36e-05	0.000751	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	2.35e-05	0.000747	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TXNRD1—epilepsy syndrome	2.34e-05	0.000746	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AQP1—epilepsy syndrome	2.27e-05	0.000724	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCG2—epilepsy syndrome	2.11e-05	0.000671	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—KCNJ11—epilepsy syndrome	2.06e-05	0.000655	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CHRM3—epilepsy syndrome	2.06e-05	0.000655	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP2C19—epilepsy syndrome	2.05e-05	0.000654	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP11A1—epilepsy syndrome	2.04e-05	0.00065	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.02e-05	0.000645	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.85e-05	0.000588	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP2D6—epilepsy syndrome	1.84e-05	0.000586	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.81e-05	0.000578	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.81e-05	0.000578	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.81e-05	0.000578	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.81e-05	0.000578	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.81e-05	0.000578	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.81e-05	0.000578	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ADRA2A—epilepsy syndrome	1.75e-05	0.000558	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—BCHE—epilepsy syndrome	1.74e-05	0.000556	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCG2—epilepsy syndrome	1.68e-05	0.000534	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC2A1—epilepsy syndrome	1.66e-05	0.00053	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.66e-05	0.000529	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.66e-05	0.000529	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.66e-05	0.000529	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.66e-05	0.000529	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PLCB1—epilepsy syndrome	1.65e-05	0.000524	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—TH—epilepsy syndrome	1.64e-05	0.000523	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP2C19—epilepsy syndrome	1.63e-05	0.00052	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP11A1—epilepsy syndrome	1.62e-05	0.000517	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.61e-05	0.000514	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.54e-05	0.000492	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.54e-05	0.000492	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.54e-05	0.00049	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	1.46e-05	0.000467	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.45e-05	0.000462	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	1.39e-05	0.000444	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—BCHE—epilepsy syndrome	1.39e-05	0.000442	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.38e-05	0.000438	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.38e-05	0.000438	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.38e-05	0.000438	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.38e-05	0.000438	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.38e-05	0.000438	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HMOX1—epilepsy syndrome	1.37e-05	0.000436	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CAT—epilepsy syndrome	1.35e-05	0.00043	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	1.32e-05	0.000422	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCB1—epilepsy syndrome	1.31e-05	0.000419	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	1.31e-05	0.000417	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TH—epilepsy syndrome	1.31e-05	0.000416	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.26e-05	0.000401	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.26e-05	0.000401	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.26e-05	0.000401	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GPX1—epilepsy syndrome	1.22e-05	0.000389	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.21e-05	0.000386	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.17e-05	0.000373	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.17e-05	0.000373	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.1e-05	0.00035	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	1.09e-05	0.000347	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CAT—epilepsy syndrome	1.07e-05	0.000342	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AGT—epilepsy syndrome	1.07e-05	0.000341	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.07e-05	0.000341	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOE—epilepsy syndrome	1.05e-05	0.000334	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	1.05e-05	0.000333	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.04e-05	0.000332	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.04e-05	0.000332	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	9.94e-06	0.000317	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	9.94e-06	0.000317	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	9.73e-06	0.00031	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GPX1—epilepsy syndrome	9.72e-06	0.00031	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ADSL—epilepsy syndrome	9.53e-06	0.000304	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GLUL—epilepsy syndrome	9.35e-06	0.000298	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	9.18e-06	0.000292	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—POMC—epilepsy syndrome	9.01e-06	0.000287	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	8.58e-06	0.000273	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AGT—epilepsy syndrome	8.52e-06	0.000272	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOE—epilepsy syndrome	8.35e-06	0.000266	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AQP1—epilepsy syndrome	8.33e-06	0.000265	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALB—epilepsy syndrome	8.22e-06	0.000262	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	7.54e-06	0.00024	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	7.54e-06	0.00024	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	7.19e-06	0.000229	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—POMC—epilepsy syndrome	7.18e-06	0.000229	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALB—epilepsy syndrome	6.54e-06	0.000208	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	6.14e-06	0.000196	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	5.99e-06	0.000191	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	5.95e-06	0.00019	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	5.72e-06	0.000182	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	5.37e-06	0.000171	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.11e-06	0.000163	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.09e-06	0.000162	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	4.86e-06	0.000155	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	4.8e-06	0.000153	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TH—epilepsy syndrome	4.79e-06	0.000152	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.99e-06	0.000127	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.94e-06	0.000126	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.83e-06	0.000122	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKT1—epilepsy syndrome	3.61e-06	0.000115	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.56e-06	0.000114	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.13e-06	9.96e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.06e-06	9.76e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKT1—epilepsy syndrome	2.88e-06	9.16e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.63e-06	8.38e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.4e-06	7.64e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.1e-06	6.69e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.05e-06	3.36e-05	CbGpPWpGaD
